D. E. SHAW & CO L.P. 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-16 4:03 pm Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
D. E. SHAW & CO L.P. | 3,215,449 4.300% |
-576,079![]() (-15.19%) |
Filing |
2020-06-15 4:11 pm Purchase |
2020-06-04 | 13G | Myriad Genetics, Inc. MYGN |
D. E. SHAW & CO L.P. | 3,791,528 5.100% |
923,114![]() (+32.18%) |
Filing |